Few treatment decision support interventions (DSIs) are available to engage patients diagnosed with late-stage non-small cell lung cancer (NSCLC) in treatment shared decision making (SDM). We designed a novel DSI that includes care plan cards and a companion patient preference clarification tool to assist in shared decision making. The cards answer common patient questions about treatment options (chemotherapy, chemotherapy plus immunotherapy, targeted therapy, immunotherapy, clinical trial participation, and supportive care). The form elicits patient treatment preference. We then conducted interviews with clinicians and patients to obtain feedback on the DSI. We also trained oncology nurse educators to implement the prototype. Finally, we pilot tested the DSI among five patients with NSCLC in treatment SDM at the beginning of an office visit scheduled to discuss Treatment with an oncologist. Analyses of pilot study baseline and exit survey data showed that DSI use was associated with increased patient awareness of the alternatives’ treatment options and benefits/risks. In contrast, patient concern about treatment costs and uncertainty in treatment decision making decreased. All patients expressed a treatment preference. Future randomized controlled trials are needed to assess DSI implementation feasibility and efficacy in clinical care.
Digital Object Identifier (DOI)
This research was funded by a grant from Genentech, Inc., “Using Genetics, Palliative Care, and Shared Decision Making to Improve Lung Cancer Care: A Developmental Study”.
Myers, Ronald E.; Advani, Shailesh M.; Myers, Pamela; Selvan, Preethi; Garber, Gregory; Worster, Brooke; Flomenberg, Neal; Chapman, Andrew; and Zinner, Ralph, "Engaging Patients with Late-Stage Non-Small Cell Lung Cancer in Shared Decision Making about Treatment" (2021). Internal Medicine Faculty Publications. 263.